Company Overview and News

10
TOTAL Buys G2mobility, Expands Vehicle Charging Businesses

2018-09-21 zacks - 1
TOTAL S.A. (TOT - Free Report) announced that it has entered into an agreement to acquire G2mobility, a French leading provider of electric vehicle charging solutions. The deal will expand the company’s footprint in electric vehicle charging businesses, ranging from designing smart charging stations to optimizing energy usage management and selling integrated services. New Energies for Mobility Rapid urbanization and development of infrastructure are resulting in massive growth in the usage of vehicles across the globe.
SPWR CLNE 5GD SRGRF PMOIF PMO PMOIY

 
CLNE / Clean Energy Fuels Corp. 8-K (Current Report)

2018-09-20 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CLNE

 
Update On CLNE And WPRT

2018-09-20 seekingalpha
Over recent months, the share prices of two companies involved in supplying services to the alternative energy sector when it comes to fueling light, medium, and heavy-duty vehicle moved higher. Both Clean Energy Fuels Corporation (CLNE) and Westport Fuel Systems (WPRT) have moved appreciably higher from their lows. However, they remain at a fraction of the highs reached in 2012.
FP CLNE 2338 WEICF WEICY

 
CLNE / Clean Energy Fuels Corp. null

2018-09-17 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0U(# @;V)J#3P\+TQI;F5A
CLNE

 
CLNE / Clean Energy Fuels Corp. null

2018-09-17 sec.gov
CORRESP 4675 MacArthur Court, Suite 800 Newport Beach, California 92660 949.437.1000 www.cleanenergyfuels.com
CLNE

41
Short Sellers Jump on One Solar, One Alt Energy Stock

2018-09-13 247wallst - 1
Short interest moves among solar and alternative energy stocks were mixed during the two-week reporting period that ended on August 31. Of the companies we watch, short interest rose on two of three solar stocks and rose on three of five alternative energy stocks. We’ve added fuel cell maker Bloom Energy to our watch list this week.
SPWR CLNE BE FCELB 5GD SRGRF PEIX FSLR CSIQ PLUG FCEL

 
Favorable Price Action In Clean Energy Fuels Corp. And Westport Fuel Systems

2018-08-30 seekingalpha
Clean Energy Fuels Corporations (CLNE) and Westport Fuel Systems (WPRT) are companies involved in supplying trucks and commercial vehicles with cleaners fuels. CLNE provides natural gas as an alternative fuel for vehicle fleets across the United States and Canada. The company designs, builds, and maintains fueling stations and sells and services natural gas fueling compressors and other equipment used in CNG and LNG stations.
FP CLNE 2338 WEICF WEICY

44
Short Sellers Search for Direction on Solar, Alt Energy Stocks

2018-08-27 247wallst - 4
Short interest moves among solar and alternative energy stocks were mixed during the two-week reporting period that ended on August 15. Of the companies we watch, short interest rose on two of three solar stocks and rose on two of four alternative energy stocks.
SPWR CLNE FCELB 5GD SRGRF PEIX FSLR CSIQ PLUG FCEL

1
CLNE / Clean Energy Fuels Corp. 424B3 (Prospectus)

2018-08-16 sec.gov - 1
424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) File No. 333-226656 PROSPECTUS
CLNE

 
Hexagon Composites ASA (HXGCF) CEO Jon Engeset on Q2 2018 Results - Earnings Call Transcript

2018-08-15 seekingalpha
Welcome, everybody, to Hexagon Composites Quarter 2 2018 Presentation. It's my pleasure to take you through the group highlights. We're going to introduce a section called Business Updates, and we'll touch on a couple of hot topics for the quarter 2 period. There will be a shortened Group Financials section after that, and then Jon Erik will come and join us for the outlook and Q&A. And we include in this presentation our Appendix on some more segment financials, but we won't go through those here today.
HXGCF CLNE

1
Update On CLNE

2018-08-11 seekingalpha - 1
In my last piece on Clean Energy Fuels Corporation published on Seeking Alpha on June 26, I had become a bit too overenthusiastic with the price action in the stock of CLNE. On that date, the shares had just eclipsed the $3 level and were on their way to highs of $4.05 on June 27.
CLNE

 
CLNE / Clean Energy Fuels Corp. / BlackRock Inc. - null (Passive Investment)

2018-08-09 sec.gov
us1844991018_080818.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) CLEAN ENERGY FUELS CORP -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 184499101 -------------------------------------------------------- (CUSIP Number) July 31, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cove
CLNE

 
CLNE / Clean Energy Fuels Corp. / BlackRock Inc. - null (Passive Investment)

2018-08-09 sec.gov
us1844991018_080818.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) CLEAN ENERGY FUELS CORP -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 184499101 -------------------------------------------------------- (CUSIP Number) July 31, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cove
CLNE

 
CLNE / Clean Energy Fuels Corp. 10-Q (Quarterly Report)

2018-08-08 sec.gov
Document Table of Contents
CLNE

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to CLNE / Clean Energy Fuels Corp. on message board site Silicon Investor.

Clean Energy Fuels (CLNE) Clean Energy Fuels (CLNE) Clean Energy Fuels (CLNE)
CUSIP: 184499101